Onko-Gene

Critical literature watch in the molecular oncology of solid tumors

FREN

Clinical · Molecular biology · Bioinfo & AI

Prognostic lncRNAs and their functional pathways in gastric cancer revealed by bioinformatics and experimental validation

Summary

This study identified six lncRNAs (SLC12A5-AS1, MAP3K2-DT, LINC02544, MIR181A2HG, LINC01914, and LNCOG) whose expression is significantly upregulated in gastric cancer. High expression of these lncRNAs is associated with unfavourable overall survival, particularly for LNCOG, LINC02544, and SLC12A5-AS1 after adjustment. Co-expression network analyses highlighted the involvement of these lncRNAs in cancer-associated pathways, notably epithelial-mesenchymal transition. These lncRNAs may hold diagnostic and prognostic value, although independent validations are required.

Critical appraisal

Clinical. This preliminary study identifies six lncRNAs as potential prognostic biomarkers in gastric cancer, with high expression associated with unfavourable overall survival. Three of them (LNCOG, LINC02544, SLC12A5-AS1) maintained a significant association after adjustment for pathological stage, age, and sex, with HRs ranging from 1.17 to 1.23. LINC01914, LNCOG, and LINC02544 showed high discriminatory performance (AUC > 0.8) in distinguishing tumour from normal tissues. These promising results require independent validation in larger cohorts before any clinical diagnostic or prognostic application can be inferred. Clinical impact is expected in 5+ years, justifying phase II trials to validate their role as potential prognostic or predictive biomarkers.

Molecular biology. The discovery of six lncRNAs (SLC12A5-AS1, MAP3K2-DT, LINC02544, MIR181A2HG, LINC01914, LNCOG) significantly upregulated in gastric cancer represents an advancement in understanding the molecular mechanisms of this disease. RT-qPCR analysis on 25 paired clinical specimens validated the differential expression observed in TCGA data. The association of these lncRNAs with epithelial-mesenchymal transition (EMT) suggests a functional role in tumour progression. These lncRNAs could serve as targets for future gene expression-based diagnostic or prognostic tests, potentially via NGS panels or quantitative PCR methods.

Bioinfo & AI. The study employed robust bioinformatics approaches, including analysis of TCGA-STAD data (412 tumour, 36 normal samples) to identify differentially expressed lncRNAs. Univariable and multivariable Cox regression analyses, along with Kaplan-Meier curves, were used to assess prognostic value. Co-expression network construction and pathway enrichment identified associated biological processes, such as EMT. These bioinformatics methods generated strong hypotheses that were subsequently partially validated experimentally, demonstrating the effectiveness of an integrative approach for biomarker discovery.

The summary and the appraisal were written by a language model from the title and abstract of the original article. A curator decided to publish it. Methodology